1-Phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) facilitates curcumin-induced melanoma cell apoptosis by enhancing ceramide accumulation, JNK activation, and inhibiting PI3K/AKT activation-Reference-Cited by-同舟云学术

1-Phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) facilitates curcumin-induced melanoma cell apoptosis by enhancing ceramide accumulation, JNK activation, and inhibiting PI3K/AKT activation

Published:2011-09-29 Issue:1-2 Volume:361 Page:47-54
ISSN:0300-8177
Container-title:Molecular and Cellular Biochemistry
language:en
Short-container-title:Mol Cell Biochem

Author:

Yu Teng,Li Jinchao,Qiu Ying,Sun Hui

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11010-011-1086-9.pdf

Reference38 articles.

1. Balch CM, Soong SJ, Gershenwald JE et al (2001) Prognostic factors analysis of 17, 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19:3622–3634

2. Balch CM, Buzaid AC, Soong SJ et al (2001) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635–3648

3. Soengas MS, Lowe SW (2003) Apoptosis and melanoma chemoresistance. Oncogene 22:3138–3151

4. Molife R, Hancock BW (2002) Adjuvant therapy of malignant melanoma. Crit Rev Oncol Hematol 44:81–102

5. Goel A, Kunnumakkara AB, Aggarwal BB (2008) Curcumin as “Curecumin”: from kitchen to clinic. Biochem Pharmacol 75:787–809

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ceramides are fuel gauges on the drive to cardiometabolic disease;Physiological Reviews;2024-07-01

2. Glycosylation editing: an innovative therapeutic opportunity in precision oncology;Molecular and Cellular Biochemistry;2024-06-11

3. Herbal nano-formulations in lung cancer: Superiorities to original forms;Journal of Medicinal Plants;2023-12-01

4. Disorders of cancer metabolism: The therapeutic potential of cannabinoids;Biomedicine & Pharmacotherapy;2023-01

5. Targeting Sphingolipid Metabolism as a Therapeutic Strategy in Cancer Treatment;Cancers;2022-04-27